Drug Type Small molecule drug |
Synonyms CLL 442, CLL442 |
Target |
Mechanism PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma | Phase 2 | US | - | |
Squamous Cell Carcinoma | Phase 2 | AU | - | |
Squamous Cell Carcinoma | Phase 2 | BE | - | |
Squamous Cell Carcinoma | Phase 2 | - | - |